PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

This study has been completed.
Information provided by:
Anthera Pharmaceuticals Identifier:
First received: March 30, 2007
Last updated: February 1, 2010
Last verified: January 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2007
  Estimated Primary Completion Date: No date given
No publications provided by Anthera Pharmaceuticals

Publications automatically indexed to this study by Identifier (NCT Number):